Literature DB >> 17447232

NK cells--from basic research to cancer therapy.

Adelheid Cerwenka1, Christine S Falk, Carsten Watzl.   

Abstract

50 scientists recently met for the Hengstberger Symposium on NK cells in Heidelberg, Germany to discuss the regulation and function of these important immune cells.

Entities:  

Mesh：

Year:  2007        PMID： 17447232     DOI： 10.1002/eji.200790017

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN： 0014-2980            Impact factor:   5.532


  4 in total

1.  Differential RNA expression of KIR alleles.

Authors:  Colum McErlean; Asensio A Gonzalez; Rodat Cunningham; Ashley Meenagh; Tanya Shovlin; Derek Middleton
Journal:  Immunogenetics       Date:  2010-05-08       Impact factor: 2.846

2.  Impact of gefitinib in early stage treatment on circulating cytokines and lymphocytes for patients with advanced non-small cell lung cancer.

Authors:  Jin Sheng; Wenfeng Fang; Xia Liu; Shan Xing; Jianhua Zhan; Yuxiang Ma; Yan Huang; Ningning Zhou; Hongyun Zhao; Li Zhang
Journal:  Onco Targets Ther       Date:  2017-02-21       Impact factor: 4.147

3.  CD11b(-)CD27(-) NK cells are associated with the progression of lung carcinoma.

Authors:  Jing Jin; Binqing Fu; Xinyu Mei; Ting Yue; Rui Sun; Zhigang Tian; Haiming Wei
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

4.  Progressive changes in composition of lymphocytes in lung tissues from patients with non-small-cell lung cancer.

Authors:  María Del Mar Valenzuela-Membrives; Francisco Perea-García; Abel Sanchez-Palencia; Francisco Ruiz-Cabello; Mercedes Gómez-Morales; María Teresa Miranda-León; Inmaculada Galindo-Angel; María Esther Fárez-Vidal
Journal:  Oncotarget       Date:  2016-11-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.